277 related articles for article (PubMed ID: 24703099)
1. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.
Brown JW; Martin PJ; Thorpe JW; Michell AW; Coles AJ; Cox AL; Vincent A; Zandi MS
J Neuroimmunol; 2014 Jun; 271(1-2):66-8. PubMed ID: 24703099
[TBL] [Abstract][Full Text] [Related]
2. Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis.
Casault C; Alikhani K; Pillay N; Koch M
J Neuroimmunol; 2015 Dec; 289():84-6. PubMed ID: 26616875
[TBL] [Abstract][Full Text] [Related]
3. Assessing the clinical features of LGI1 antibody encephalitis.
Zhao PP; Zhang Y; Gao L; Sun L
Acta Neurol Belg; 2016 Mar; 116(1):109-12. PubMed ID: 26220774
[No Abstract] [Full Text] [Related]
4. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
5. Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy.
Szots M; Marton A; Kover F; Kiss T; Berki T; Nagy F; Illes Z
J Neurol Sci; 2014 Aug; 343(1-2):198-202. PubMed ID: 24928080
[TBL] [Abstract][Full Text] [Related]
6. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
[No Abstract] [Full Text] [Related]
8. [Leucine-rich glioma inactivated-1 protein antibody associated limbic encephalitis: one case report].
Zheng YM; Sun W; Wang ZX; Zhang W; Yuan Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):646-9. PubMed ID: 25131487
[TBL] [Abstract][Full Text] [Related]
9. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
10. Faciobrachial dystonic seizures and antibodies to Lgi1 in a 92-year-old patient: a case report.
Fidzinski P; Jarius S; Gaebler C; Boegner F; Nohr R; Ruprecht K
J Neurol Sci; 2014 Dec; 347(1-2):404-5. PubMed ID: 25455306
[No Abstract] [Full Text] [Related]
11. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
14. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.
Navarro V; Kas A; Apartis E; Chami L; Rogemond V; Levy P; Psimaras D; Habert MO; Baulac M; Delattre JY; Honnorat J;
Brain; 2016 Apr; 139(Pt 4):1079-93. PubMed ID: 26945884
[TBL] [Abstract][Full Text] [Related]
15. Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature.
Karvigh SA; Salehizadeh S; Vahabizad F
J Med Case Rep; 2022 Nov; 16(1):409. PubMed ID: 36348436
[TBL] [Abstract][Full Text] [Related]
16. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
Chen L; Su T; Liu Y
BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
[TBL] [Abstract][Full Text] [Related]
18. Pilomotor Seizures in a Patient With LGI1 Encephalitis.
Yang J; Sun Q; Yang G
Front Neurol; 2020; 11():61. PubMed ID: 32153488
[TBL] [Abstract][Full Text] [Related]
19. The importance of early immunotherapy in patients with faciobrachial dystonic seizures.
Thompson J; Bi M; Murchison AG; Makuch M; Bien CG; Chu K; Farooque P; Gelfand JM; Geschwind MD; Hirsch LJ; Somerville E; Lang B; Vincent A; Leite MI; Waters P; Irani SR;
Brain; 2018 Feb; 141(2):348-356. PubMed ID: 29272336
[TBL] [Abstract][Full Text] [Related]
20. [Unexplicated neuropsychiatric disorders: Do not ignore dysimmune encephalitis. A case report of a dysimmune encephalitis with anti-leucine rich glioma inactivated 1 (LGI-1) antibodies].
Le Dault E; Lagarde S; Guedj E; Dufournet B; Rey C; Kaphan E; Tanguy G; Bregigeon M; Sagui E; Brosset C
Rev Med Interne; 2016 Feb; 37(2):127-30. PubMed ID: 26164401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]